Arginase inhibition ameliorates hepatic metabolic abnormalities in obese mice.
about
Targeting arginase-II protects mice from high-fat-diet-induced hepatic steatosis through suppression of macrophage inflammation.Alterations in Circulating Amino Acid Metabolite Ratio Associated with Arginase Activity Are Potential Indicators of Metabolic Syndrome: The Korean Genome and Epidemiology Study.Early obesity leads to increases in hepatic arginase I and related systemic changes in nitric oxide and L-arginine metabolism in mice.Arginase inhibition prevents the development of hypertension and improves insulin resistance in obese rats.
P2860
Arginase inhibition ameliorates hepatic metabolic abnormalities in obese mice.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Arginase inhibition ameliorates hepatic metabolic abnormalities in obese mice.
@ast
Arginase inhibition ameliorates hepatic metabolic abnormalities in obese mice.
@en
type
label
Arginase inhibition ameliorates hepatic metabolic abnormalities in obese mice.
@ast
Arginase inhibition ameliorates hepatic metabolic abnormalities in obese mice.
@en
prefLabel
Arginase inhibition ameliorates hepatic metabolic abnormalities in obese mice.
@ast
Arginase inhibition ameliorates hepatic metabolic abnormalities in obese mice.
@en
P2093
P2860
P1433
P1476
Arginase inhibition ameliorates hepatic metabolic abnormalities in obese mice.
@en
P2093
Hyun Ju Do
Jiyoung Moon
Min-Jeong Shin
Yoonsu Cho
P2860
P304
P356
10.1371/JOURNAL.PONE.0103048
P407
P577
2014-07-24T00:00:00Z